HOOKIPA Pharma And 3 Other Stocks Under $2 Insiders Are Aggressively Buying

The Dow Jones closed slightly higher on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Broad Street Realty

• The Trade: Broad Street Realty, Inc. BRST CEO Michael Z Jacoby acquired a total 3,000 shares an average price of $0.89. To acquire these shares, it cost around $2,670.
• What’s Happening: The company’s stock dropped 7% over the past month.
• What Broad Street Realty Does: Broad Street Realty Inc is a fully integrated real estate company that owns, operates, develops, and redevelops grocery-anchored shopping centers and street retail-based properties in the Mid-Atlantic and Denver, Colorado markets.

Stran & Company

• The Trade: Stran & Company, Inc. SWAG (Director, EC, Treasurer & Sec. Andrew Stranberg acquired a total of 12,630 shares at an average price of $1.50. The insider spent around $19,000.
• What’s Happening: Stran & Co posted a narrower-than-expected first-quarter loss.
• What Stran & Company Does: Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise.

HOOKIPA Pharma

• The Trade: HOOKIPA Pharma Inc. HOOK CFO Reinhard Kandera acquired a total of 12,000 shares at an average price of $0.88. To acquire these shares, it cost around 10,560.
• What’s Happening: HOOKIPA Pharma recently announced preliminary Phase 2 data on HB-200 in combination with pembrolizumab in patients with HPV16+ head and neck cancers.
• What HOOKIPA Pharma Does: HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system.

Check This Out: Top 5 Consumer Stocks That May Implode This Quarter

Don’t forget to check out our premarket coverage here

Texas Mineral Resources

• The Trade: Texas Mineral Resources Corp. TMRC Director Cecil C Wall acquired a total of 10,000 shares at an average price of $0.81. The insider spent $8,065 to buy those shares.
• What’s Happening: The company’s shares dipped 36% over the past six months.
• What Texas Mineral Resources Does: Texas Mineral Resources Corp is an exploration-stage mining company. It is primarily engaged in the business of acquisition, exploration, and development of mineral properties.